Marker | COVID-19 Severity | Mean ± Standard Deviation (number of available data) | ANCOVAa | ||||
---|---|---|---|---|---|---|---|
Periodontitis Severity Group | Modelb | P Value | |||||
HP | MP | SP | Total | ||||
Serum CRP (mg/dL) | MC | 18.48 ± 23.52 (26) | 27.77 ± 23.96 (22) | 38.09 ± 24.11 (11) | 25.60 ± 24.51 (59) | COVID-19 Only | 0.063 |
Periodontitis Only | 0.098 | ||||||
SC | 26.43 ± 23.64 (7) | 40.44 ± 25.06 (12) | 32.75 ± 24.74 (24) | 33.87 ± 24.53 (43) | Interaction Model: | ||
COVID-19 | 0.152 | ||||||
Total | 20.17 ± 23.41 (33) | 32.24 ± 24.75 (34) | 34.43 ± 24.32 (35) | 29.09 ± 24.74 (102) | Periodontitis | 0.131 | |
COVID-19 × Perio | 0.225 | ||||||
Saliva CRP (mg/dL) | MC | 0.83 ± 1.68 (26) | 1.27 ± 2.69 (22) | 2.45 ± 2.91 (11) | 1.30 ± 2.38 (59) | COVID-19 Only | 0.230 |
Periodontitis Only | 0.080 | ||||||
SC | 0.43 ± 1.13 (7) | 2.33 ± 2.39 (12) | 1.87 ± 2.66 (24) | 1.77 ± 2.44 (43) | Interaction Model: | ||
COVID-19 | 0.587 | ||||||
Total | 0.75 ± 1.58 (33) | 1.65 ± 2.60 (34) | 2.06 ± 2.71 (35) | 1.50 ± 2.40 (102) | Periodontitis | 0.063 | |
COVID-19 × Perio | 0.276 | ||||||
Serum IL-6 (pg/dL) | MC | 5.52 ± 8.71 (25) | 9.82 ± 14.03 (25) | 9.71 ± 8.81 (11) | 8.04 ± 11.25 (61) | COVID-19 Only | < 0.001* |
Periodontitis Only | 0.002* | ||||||
SC | 9.53 ± 6.09 (7) | 15.13 ± 14.28 (14) | 23.52 ± 23.56 (25) | 18.84 ± 19.74 (46) | Interaction Model: | ||
COVID-19 | 0.002* | ||||||
Total | 6.39 ± 8.29 (32) | 11.73 ± 14.16 (39) | 19.30 ± 21.08 (36) | 12.68 ± 16.31 (107) | Periodontitis | 0.101 | |
COVID-19 × Perio | 0.596 | ||||||
Saliva IL-6 (pg/dL) | MC | 1.37 ± 1.56 (25) | 3.28 ± 5.39 (25) | 3.11 ± 2.55 (11) | 2.47 ± 3.81 (61) | COVID-19 Only | < 0.001* |
Periodontitis Only | 0.006* | ||||||
SC | 2.43 ± 1.52 (7) | 5.35 ± 6.14 (14) | 7.17 ± 8.22 (25) | 5.90 ± 7.08 (46) | Interaction Model: | ||
COVID-19 | 0.004* | ||||||
Total | 1.60 ± 1.59 (32) | 4.03 ± 5.68 (39) | 5.93 ± 7.20 (36) | 3.94 ± 5.69 (107) | Periodontitis | 0.101 | |
COVID-19 × Perio | 0.744 |